so what. they just patented some compound that's in medchem most likely. like 6 years away from the market if it works. it could be an extension on an existing compound further along too. we need clinical trail data. otherwise, this isn't moving. there are lots of talks and buyouts in pharma. just not here. that might tell us something about their pipeline or lack thereof.
I told you 5 big pharmas gave my company millions and bought shares. the company is almost bust. they all lost and moved on. New hedge funds and investors moved in but they will lose too. So just because these guys bought, doesn't mean squat other than they had money and gave it away
they bundle sell orders till they get enough to cover the buy. it might take some time but the buyer waits and then they take all the sells and give them the shares.
give it up. the market is selling drilling companies like they did gold a couple of years ago. then they all rebounded 50% or more in 6 months.
don't think you can. lists shares and amount at the current price but I'm not sure we can know what and how many at a price. I'm in RIG at 49's, DO at 55's, SDRL at 40's and NE in upper 30's. I have 90% of my money in them. I'm dying.
so true. big pharma can run 50 trials to maximize the potential. ariad doesn't but I think berger wants that magic trial or compound to get over 30-40 vs. 20. I'm not sure if denner shopped around but he might get 17-20 and his average is 3 something I think someone said. that's great for him but for the employees and berger who might have a lot of options above 15, it's squat. so we either hit 30 or 1. time will tell where we go. Too bad I put 150K in this sheet instead of FB or some other lame stock that went up 400% in a year.
keep in mind, there might be 20 steps and he's just one into it. I can't see him going unless he screws up all the trials and by then, the stock will be under a buck and we'll have written off our losses and moved on. by the time he's toast, we're toast also.
you mean he's "not fit" to run the company. I think he wants some crazy high number for his company/shares that won't ever happen. he should take 25 and be a subsidiary in the new company and keep his job.
it's sarcasm. I'm stating that I want a trial to work and to have good news. ARIA is devoid of such for a long time.
since they won't have any meaningful news for 10 years, ARIA mgt decided to let all of the PR dept go for now. When they get some clinical data (when pigs fly), they will rehire those who are eligible (and not dead by then).
I have a friend who just joined aria as a scientist. she said at several meetings, the timeline for clinical trial data is around 2025. They want to run them long enough and well enough to be perfect. they will run out of money in 2019 but they trials will go on till 2025. then they will put some news out for longs to enjoy. Until then, forget it. they are so tight lipped it makes a crab's #$%$ less than water proof.
you've got to wonder why he's buying so much and wants more per ariad investor. either he's fooled like us longs or knows/feels this is worth way higher a price. I bet he's shopped around and has gotten interest but berger won't sell south of 40 or 50. get rid of berger and take $25 and be done with it.
get lost. if I had a buck for every stock message board that you posted it was upgraded and to visit pennysheettocksweekly, I'd have my loses in aria made up. go back to high school and get your degree.
sounds like denner wants the dumb sheet out of the CEO chair and out on the street. I bet Denner can get $20 or more and Berger says no. Can't the guy and get down to business. I don't have 20 years for this to hit 20.